Report Detail

Request for Sample of this report

Colorectal (Colon) Cancer- Market Insights, Epidemiology and Market Forecast 2028

RnM3517293
11 June, 2019
Global
92 Pages
MIReports
Other

Report Summary

"Colorectal (Colon) Cancer- Market Insights, Epidemiology and Market Forecast 2028" report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2016-2028.

Market Segment by Countries, covering：
United States
EU5 (Germany, France, Italy, Spain and the United Kingdom)
Japan

Study Period: 2016-2028

Colorectal (Colon) Cancer Understanding and Treatment Algorithm
The report provides the in depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about treatment algorithms and treatment guidelines for Colorectal (Colon) Cancerin the US, Europe, and Japan are also provided in the report.

Colorectal (Colon) Cancer Epidemiology
This section provide the insights about historical and current patient pool and forecasted trend for 7 major markets. It takes in to account the analysis of numerous studies, survey reports as well as KOL’s views which helps to recognize the factors behind the current and forecasted trends, diagnosed and treatable patient pool along with assumptions undertaken.

Colorectal (Colon) Cancer Product Profiles & Analysis
This part of the Colorectal (Colon) Cancer report encloses the detailed analysis of marketed drugs and Phase III and late Phase II pipeline drugs. It provides the key cross competition which evaluates the drugs on several parameters including, safety & efficacy results, mechanism of action, route, launch dates and designations. This section also covers the market intelligence and tracking of latest happenings, agreements and collaborations, approvals, patent details and other major breakthroughs.

Colorectal (Colon) Cancer Market Outlook
The Colorectal (Colon) Cancer market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment analyses the market trend of each marketed drug and late-stage pipeline drugs. This is done by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders . The calculated market data is presented with relevant tables and graphs to give a clear view of the market at first sight.

Colorectal (Colon) Cancer Market Share by Therapies
This section focusses on the rate of uptake of the potential drugs recently launched or will be launched in the market during the study period from 2016-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug. This information also helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It provides the comparison of the drugs on the basis of market share and size. This analysis helps in investigating factors important in market uptake and in making financial as well as regulatory decisions.

Colorectal (Colon) Cancer Report Insights
Patient Population in Colorectal (Colon) Cancer
Therapeutic Approaches in Colorectal (Colon) Cancer
Colorectal (Colon) Cancer Pipeline Analysis
Colorectal (Colon) Cancer Market Size and Trends
Colorectal (Colon) Cancer Market Opportunities
Impact of upcoming Therapies in Colorectal (Colon) Cancer

Colorectal (Colon) Cancer Report Key Strengths
10 Year Forecast
7MM Coverage
Epidemiology Segmentation
Drugs Uptake
Highly Analyzed Market
Key Cross Competition

Colorectal (Colon) Cancer Report Assessment
Current Treatment Practices in Colorectal (Colon) Cancer
Unmet Needs in Colorectal (Colon) Cancer
Detailed Colorectal (Colon) Cancer Pipeline Product Profiles
Market Attractiveness
Market Drivers and Barriers

Key Benefits

This report will help to develop Business Strategies by understanding the trends shaping and driving the Colorectal (Colon) Cancer market
Organize sales and marketing efforts by identifying the best opportunities for Colorectal (Colon) Cancer market
To understand the future market competition in the Colorectal (Colon) Cancer market.

Note: We understand the needs of the rapidly changing market and is helping the client by providing the most up to date Report. It usually takes 4-5 days to deliver this kind of Report. The report coverage will depend on the availability of the data.
Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

1 Key Insights

2 Colorectal (Colon) Cancer Market Overview at a Glance

2.1 Market Share (%) Distribution of Colorectal (Colon) Cancer in 2018
2.2 Market Share (%) Distribution of Colorectal (Colon) Cancer in 2028

3 Colorectal (Colon) Cancer: Disease Background and Overview

3.1 Introduction
3.2 Symptoms
3.3 Etiology
3.4 Risk Factor
3.5 Pathophysiology
3.6 Diagnosis
3.7 Treatment

4 Epidemiology and Patient Population

4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Colorectal (Colon) Cancer in 7MM
4.3. Total Prevalent Patient Population of Colorectal (Colon) Cancer in 7MM – By Countries

5 Epidemiology of Colorectal (Colon) Cancer by Countries (2016-2028)

5.1 United States- Epidemiology (2016-2028)
- 5.1.1 Assumptions and Rationale
- 5.1.2 Prevalent/Incident Cases of Colorectal (Colon) Cancer in the United States
- 5.1.3 Sub-Type Specific cases of Colorectal (Colon) Cancer in the United States
- 5.1.4 Sex- Specific Cases of Colorectal (Colon) Cancer in the United States
- 5.1.5 Diagnosed Cases of Colorectal (Colon) Cancer in the United States
- 5.1.6 Treatable Cases of Colorectal (Colon) Cancer in the United States
5.2 EU5 Countries
- 5.2.1 Germany
  - 5.2.1.1 Assumptions and Rationale
  - 5.2.1.2 Prevalent/Incident Cases of the of Colorectal (Colon) Cancer in the Germany
  - 5.2.1.3 Sub-Type Specific cases of Colorectal (Colon) Cancer in the Germany
  - 5.2.1.4 Sex- Specific Cases of the Colorectal (Colon) Cancer in the Germany
  - 5.2.1.5 Diagnosed Cases of the Colorectal (Colon) Cancer in the Germany
  - 5.2.1.6 Treatable Cases of the Colorectal (Colon) Cancer
- 5.2.2 France
  - 5.2.2.1 Assumptions and Rationale
  - 5.2.2.2 Prevalent/Incident Cases of the of Colorectal (Colon) Cancer in the France
  - 5.2.2.3 Sub-Type Specific cases of Colorectal (Colon) Cancer in the France
  - 5.2.2.4 Sex- Specific Cases of the Colorectal (Colon) Cancer in the France
  - 5.2.2.5 Diagnosed Cases of the Colorectal (Colon) Cancer in the France
  - 5.2.2.6 Treatable Cases of the Colorectal (Colon) Cancer
- 5.2.3 Italy
  - 5.2.3.1 Assumptions and Rationale
  - 5.2.3.2 Prevalent/Incident Cases of the of Colorectal (Colon) Cancer in the Italy
  - 5.2.3.3 Sub-Type Specific cases of Colorectal (Colon) Cancer in the Italy
  - 5.2.3.4 Sex- Specific Cases of the Colorectal (Colon) Cancer in the Italy
  - 5.2.3.5 Diagnosed Cases of the Colorectal (Colon) Cancer in the Italy
  - 5.2.3.6 Treatable Cases of the Colorectal (Colon) Cancer
- 5.2.4 Spain
  - 5.2.4.1 Assumptions and Rationale
  - 5.2.4.2 Prevalent/Incident Cases of the of Colorectal (Colon) Cancer in the Spain
  - 5.2.4.3 Sub-Type Specific cases of Colorectal (Colon) Cancer in the Spain
  - 5.2.4.4 Sex- Specific Cases of the Colorectal (Colon) Cancer in the Spain
  - 5.2.4.5 Diagnosed Cases of the Colorectal (Colon) Cancer in the Spain
  - 5.2.4.6 Treatable Cases of the Colorectal (Colon) Cancer
- 5.2.5 United Kingdom
  - 5.2.5.1 Assumptions and Rationale
  - 5.2.5.2 Prevalent/Incident Cases of the of Colorectal (Colon) Cancer in the United Kingdom
  - 5.2.5.3 Sub-Type Specific cases of Colorectal (Colon) Cancer in the United Kingdom
  - 5.2.5.4 Sex- Specific Cases of the Colorectal (Colon) Cancer in the United Kingdom
  - 5.2.5.5 Diagnosed Cases of the Colorectal (Colon) Cancer in the United Kingdom
  - 5.2.5.6 Treatable Cases of the Colorectal (Colon) Cancer
5.3 Japan
- 5.3.1 Assumptions and Rationale
- 5.3.2 Prevalent/Incident Cases of the of Colorectal (Colon) Cancer in the Japan
- 5.3.3 Sub-Type Specific cases of Colorectal (Colon) Cancer in the Japan
- 5.3.4 Sex- Specific Cases of the Colorectal (Colon) Cancer in the Japan
- 5.3.5 Diagnosed Cases of the Colorectal (Colon) Cancer in the Japan
- 5.3.6 Treatable Cases of the Colorectal (Colon) Cancer

6 Current Treatment & Medical practices

6.1 Treatment Algorithm
6.2 Treatment Guidelines

7 Unmet Needs

8 Marketed Product

8.1 Drug A: Company 1
- 8.1.1 Drug Description
- 8.1.2 Mechanism of Action
- 8.1.3 Clinical Trials Details
- 8.1.4 Advantages & Disadvantages
- 8.1.5 Safety and Efficacy
- 8.1.6 Product Profile
8.2 Drug B: Company 2
- 8.2.1 Drug Description
- 8.2.2 Mechanism of Action
- 8.2.3 Clinical Trials Details
- 8.2.4 Advantages & Disadvantages
- 8.2.5 Safety and Efficacy
- 8.2.6 Product Profile
8.3 Drug C: Company 3
- 8.3.1 Drug Description
- 8.3.2 Mechanism of Action
- 8.3.3 Clinical Trials Details
- 8.3.4 Advantages & Disadvantages
- 8.3.5 Safety and Efficacy
- 8.3.6 Product Profile
8.4 Drug D: Company 4
- 8.4.1 Drug Description
- 8.4.2 Mechanism of Action
- 8.4.3 Clinical Trials Details
- 8.4.4 Advantages & Disadvantages
- 8.4.5 Safety and Efficacy
- 8.4.6 Product Profile
8.5 Drug E: Company 5
- 8.5.1 Drug Description
- 8.5.2 Mechanism of Action
- 8.5.3 Clinical Trials Details
- 8.5.4 Advantages & Disadvantages
- 8.5.5 Safety and Efficacy
- 8.5.6 Product Profile
8.6 : Company 6
- 8.6.1 Drug Description
- 8.6.2 Mechanism of Action
- 8.6.3 Clinical Trials Details
- 8.6.4 Advantages & Disadvantages
- 8.6.5 Safety and Efficacy
- 8.6.6 Product Profile
8.7 : Company 7
- 8.7.1 Drug Description
- 8.7.2 Mechanism of Action
- 8.7.3 Clinical Trials Details
- 8.7.4 Advantages & Disadvantages
- 8.7.5 Safety and Efficacy
- 8.7.6 Product Profile
8.8 : Company 8
- 8.8.1 Drug Description
- 8.8.2 Mechanism of Action
- 8.8.3 Clinical Trials Details
- 8.8.4 Advantages & Disadvantages
- 8.8.5 Safety and Efficacy
- 8.8.6 Product Profile

9 Emerging Drugs

9.1 Key Cross Competition
9.2 Emerging company
- 9.2.1 Emerging Drug A: Company 1
  - 9.2.1.1 Other Development Activities
  - 9.2.1.2 Clinical Development
  - 9.2.1.3 Clinical Trials Information
  - 9.2.1.4 Safety and Efficacy
  - 9.2.1.5 Advantages and Disadvantages
  - 9.2.1.6 Product Profile
- 9.2.2 Emerging Drug B: Company 2
  - 9.2.2.1 Other Development Activities
  - 9.2.2.2 Clinical Development
  - 9.2.2.3 Clinical Trials Information
  - 9.2.2.4 Safety and Efficacy
  - 9.2.2.5 Advantages and Disadvantages
  - 9.2.2.6 Product Profile
- 9.2.3 Emerging Drug C: Company 3
  - 9.2.3.1 Other Development Activities
  - 9.2.3.2 Clinical Development
  - 9.2.3.3 Clinical Trials Information
  - 9.2.3.4 Safety and Efficacy
  - 9.2.3.5 Advantages and Disadvantages
  - 9.2.3.6 Product Profile
- 9.2.4 Emerging Drug D: Company 4
  - 9.2.4.1 Other Development Activities
  - 9.2.4.2 Clinical Development
  - 9.2.4.3 Clinical Trials Information
  - 9.2.4.4 Safety and Efficacy
  - 9.2.4.5 Advantages and Disadvantages
  - 9.2.4.6 Product Profile
- 9.2.5 Emerging Drug E: Company 5
  - 9.2.5.1 Other Development Activities
  - 9.2.5.2 Clinical Development
  - 9.2.5.3 Clinical Trials Information
  - 9.2.5.4 Safety and Efficacy
  - 9.2.5.5 Advantages and Disadvantages
  - 9.2.5.6 Product Profile
10 7MM Market Analysis
- 10.1 7MM Market Size of Colorectal (Colon) Cancer
- 10.2 7MM Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer
- 10.3 7MM Market Sales of Colorectal (Colon) Cancer by Products
11 The United States Market Outlook
- 11.1 Market Size of Colorectal (Colon) Cancer in United States
- 11.2 Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer in United States
- 11.3 Market Sales of Colorectal (Colon) Cancer by Products in United States
- 11.4 Analysis of Upcoming Therapies and Impact on the Market
12 EU5 Countries Market Outlook
- 12.1 Market Size of Colorectal (Colon) Cancer in EU5
- 12.2 Market Size of Colorectal (Colon) Cancer in Germany
  - 12.2.1 Market Size of Colorectal (Colon) Cancer in Germany
  - 12.2.2 Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer in Germany
  - 12.2.3 Market Sales of Colorectal (Colon) Cancer by Products in Germany
  - 12.2.4 Analysis of Upcoming Therapies and Impact on the Market
- 12.3 Market Size of Colorectal (Colon) Cancer in France
  - 12.3.1 Market Size of Colorectal (Colon) Cancer in France
  - 12.3.2 Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer in France
  - 12.3.3 Market Sales of Colorectal (Colon) Cancer by Products in France
  - 12.3.4 Analysis of Upcoming Therapies and Impact on the Market
- 12.4 Market Size of Colorectal (Colon) Cancer in Italy
  - 12.4.1 Market Size of Colorectal (Colon) Cancer in Italy
  - 12.4.2 Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer in Italy
  - 12.4.3 Market Sales of Colorectal (Colon) Cancer by Products in Italy
  - 12.4.4 Analysis of Upcoming Therapies and Impact on the Market
- 12.5 Market Size of Colorectal (Colon) Cancer in Spain
  - 12.5.1 Market Size of Colorectal (Colon) Cancer in Spain
  - 12.5.2 Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer in Spain
  - 12.5.3 Market Sales of Colorectal (Colon) Cancer by Products in Spain
  - 12.5.4 Analysis of Upcoming Therapies and Impact on the Market
- 12.6 Market Size of Colorectal (Colon) Cancer in United Kingdom
  - 12.6.1 Market Size of Colorectal (Colon) Cancer in United Kingdom
  - 12.6.2 Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer in United Kingdom
  - 12.6.3 Market Sales of Colorectal (Colon) Cancer by Products in United Kingdom
  - 12.6.4 Analysis of Upcoming Therapies and Impact on the Market
13 The Japan Market Outlook
- 13.1 Market Size of Colorectal (Colon) Cancer in Japan
- 13.2 Percentage Share of Drugs Marketed for Colorectal (Colon) Cancer in Japan
- 13.3 Market Sales of Colorectal (Colon) Cancer by Products in Japan
- 13.4 Analysis of Upcoming Therapies and Impact on the Market
14 Cost Analysis of Colorectal (Colon) Cancer
15 Generic Competition in Colorectal (Colon) Cancer Market
16 Market Drivers
17 Market Barriers
18 Report Methodology
- 18.1 Methodology/Research Approach
- 18.2 Data Source
  - 18.2.1 Secondary Sources

Gynecologic Cancers Market Report

Campylobacteriosis Market Report

Summary:
Get latest Market Research Reports on Colorectal (Colon) Cancer. Industry analysis & Market Report on Colorectal (Colon) Cancer is a syndicated market report, published as Colorectal (Colon) Cancer- Market Insights, Epidemiology and Market Forecast 2028. It is complete Research Study and Industry Analysis of Colorectal (Colon) Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 11 June, 2019

1-User License	$5,980.00
1-5 User License	$12,980.00
Site License	$12,980.00
Enterprise License	$12,980.00

1-User License	4,622.54
1-5 User License	10,033.54
Site License	10,033.54
Enterprise License	10,033.54

1-User License	5,513.56
1-5 User License	11,967.56
Site License	11,967.56
Enterprise License	11,967.56

1-User License	913,504.80
1-5 User License	1,982,824.80
Site License	1,982,824.80
Enterprise License	1,982,824.80

1-User License	502,977.80
1-5 User License	1,091,747.80
Site License	1,091,747.80
Enterprise License	1,091,747.80

Report Detail

Request for Sample of this report

Request for Sample of this report

Colorectal (Colon) Cancer- Market Insights, Epidemiology and Market Forecast 2028

Table Of Content

Table of Contents

1 Key Insights

2 Colorectal (Colon) Cancer Market Overview at a Glance

3 Colorectal (Colon) Cancer: Disease Background and Overview

4 Epidemiology and Patient Population

5 Epidemiology of Colorectal (Colon) Cancer by Countries (2016-2028)

6 Current Treatment & Medical practices

7 Unmet Needs

8 Marketed Product

9 Emerging Drugs

10 7MM Market Analysis

11 The United States Market Outlook

12 EU5 Countries Market Outlook

13 The Japan Market Outlook

14 Cost Analysis of Colorectal (Colon) Cancer

15 Generic Competition in Colorectal (Colon) Cancer Market

16 Market Drivers

17 Market Barriers

18 Report Methodology

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter